Tissue transglutaminase: an emerging target for therapy and imaging

Bioorg Med Chem Lett. 2013 Dec 15;23(24):6528-43. doi: 10.1016/j.bmcl.2013.09.060.

Abstract

Tissue transglutaminase (transglutaminase 2) is a multifunctional enzyme with many interesting properties resulting in versatile roles in both physiology and pathophysiology. Herein, the particular involvement of the enzyme in human diseases will be outlined with special emphasis on its role in cancer and in tissue interactions with biomaterials. Despite recent progress in unraveling the different cellular functions of transglutaminase 2, several questions remain. Transglutaminase 2 features in both confirmed and some still ambiguous roles within pathological conditions, raising interest in developing inhibitors and imaging probes which target this enzyme. One important prerequisite for identifying and characterizing such molecular tools are reliable assay methods to measure the enzymatic activity. This digest Letter will provide clarification about the various assay methods described to date, accompanied by a discussion of recent progress in the development of inhibitors and imaging probes targeting transglutaminase 2.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / therapeutic use
  • GTP-Binding Proteins / antagonists & inhibitors*
  • GTP-Binding Proteins / metabolism
  • Humans
  • Kinetics
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy
  • Neoplasms / enzymology
  • Peptides / chemistry
  • Peptides / metabolism
  • Protein Glutamine gamma Glutamyltransferase 2
  • Structure-Activity Relationship
  • Transglutaminases / antagonists & inhibitors*
  • Transglutaminases / metabolism

Substances

  • Enzyme Inhibitors
  • Peptides
  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases
  • GTP-Binding Proteins